Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Faroha is a prominent South Korean supplier and distributor of medical aesthetic products, specializing in dermal fillers, botulinum toxins, and advanced skin boosters. The company serves as a global gateway for high-quality Korean aesthetic solutions, offering a comprehensive portfolio that includes established brands such as Neuramis, Botulax, Sculptra, and Innotox. Faroha's business model focuses on providing healthcare professionals with authentic medical devices and therapeutic agents for non-surgical cosmetic procedures, including wrinkle reduction, facial volumizing, and skin rejuvenation. In addition to distribution, the company provides technical documentation and clinical data to support the safe and effective administration of its supplied products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Faroha.